openPR Logo
Press release

Insulin Delivery Devices Market Analysis, Trends, Growth, Share and Forecast - 2027

04-05-2021 02:03 PM CET | Health & Medicine

Press release from: Orion Market Reports

Insulin Delivery Devices market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market.

Insulin delivery devices market is projected to reach USD 17.85 Billion by 2021 from USD 11.54 Billion in 2016, growing at a CAGR of 9% during the forecast period.

(Get 15% Discount on Buying this Report)

A full report of Global Insulin Delivery Devices Market is available at: https://www.orionmarketreports.com/insulin-delivery-devices-3-market/50683/

Key players in the global insulin delivery devices market include Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Medtronic plc (Ireland), Animas Corporation (U.S.), Tandem Diabetes Care, Inc. (U.S.), Sanofi (France), Biocon Ltd. (India), Eli Lilly and Company (U.S.), and Insulet Corporation (U.S.).

Insulin Delivery Devices Market, by Type

• External/Tethered Pumps
• Patch Pumps
• Pen Needles
• Standard Pen Needles
• Safety Pen Needles
• Syringes
• Other Devices

Insulin Delivery Devices Market, by End User

• Patients/Homecare
• Hospitals & Clinics

Scope of the Report

The research study analyzes the global Insulin Delivery Devices industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Insulin Delivery Devices Market Report

1. What was the Insulin Delivery Devices Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).
2. What will be the CAGR of Insulin Delivery Devices Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Insulin Delivery Devices Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

The report covers the following objectives:

• Proliferation and maturation of trade in the global Insulin Delivery Devices market.
• The market share of the global Insulin Delivery Devices market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Insulin Delivery Devices market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Insulin Delivery Devices market.

Media Contact:

Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404

About Us:

Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insulin Delivery Devices Market Analysis, Trends, Growth, Share and Forecast - 2027 here

News-ID: 2265973 • Views:

More Releases from Orion Market Reports

Diabetic Neuropathic Pain Drug Market Sluggish Growth Rate Foreseen by 2024-2031
Diabetic Neuropathic Pain Drug Market Sluggish Growth Rate Foreseen by 2024-2031
The Diabetic Neuropathic Pain Drug Market size is expected to grow at an annual average of CAGR 5% during the forecast period (2024-2031). Diabetic neuropathic pain is a chronic condition resulting from nerve damage caused by diabetes, leading to symptoms such as burning, tingling, and numbness, particularly in the feet and hands. The Diabetic Neuropathic Pain Drug Market focuses on treatments designed to manage and alleviate these painful symptoms. Effective
Mantle Cell Lymphoma Treatment Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2024 to 2031)
Mantle Cell Lymphoma Treatment Market is Anticipated to Increase at a Stable CAG …
The Mantle Cell Lymphoma Treatment Market size is expected to grow at an annual average of CAGR 7% during the forecast period (2024-2031). Mantle Cell Lymphoma (MCL) is a rare and aggressive type of non-Hodgkin lymphoma that arises from the B-cells in the outer edge of a lymph node follicle, known as the mantle zone. It is characterized by a poor prognosis and a high likelihood of relapse, making the
Allergic Asthma Therapeutics Market to Signify Strong Growth by 2024-2031
Allergic Asthma Therapeutics Market to Signify Strong Growth by 2024-2031
The Allergic Asthma Therapeutics Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). The Allergic Asthma Therapeutics Market focuses on pharmaceuticals and treatments designed to manage and alleviate symptoms associated with allergic asthma, a type of asthma triggered by allergens such as pollen, dust mites, pet dander, or mold. Allergic asthma is characterized by airway inflammation and hyperreactivity, leading to symptoms
Seasonal Allergic Rhinitis Drug Market Is Likely to Experience a Tremendous Growth by 2031
Seasonal Allergic Rhinitis Drug Market Is Likely to Experience a Tremendous Grow …
The Seasonal Allergic Rhinitis Drug Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). The Seasonal Allergic Rhinitis Drug Market focuses on pharmaceuticals and treatments designed to alleviate symptoms associated with seasonal allergic rhinitis, commonly known as hay fever. Seasonal allergic rhinitis is an allergic reaction to specific allergens, such as pollen from trees, grasses, or weeds, that occurs primarily during

All 5 Releases


More Releases for Insulin

Insulin Patch Pumps Market Report 2018: Segmentation by Insulin Type (Bolus Insu …
Global Insulin Patch Pumps market research report provides company profile for Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Becton Dickenson & Company, Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,
Bluetooth connected smart insulin pens represent the future of insulin delivery …
Increasing pool of diabetic patients witnessed across the globe has prompted leading manufacturers of medical devices towards development of ground-breaking products. Smart insulin pens are among such devices that have revolutionised the global market for diabetic injection pens. A recent study published by Future Market Insights projects that the global smart insulin pens market, which is currently valued at US$ 0.86 Mn, will expand vigorously at 17.9% CAGR through the
Insulin pump Market Explore Future Growth 2018-2026 by Global Type-Traditional i …
Insulin pump is a portable device attached to the body that continuously delivers preset amounts of short or rapid acting insulin in the body to control diabetes. Insulin therapy is required in type 1 diabetes and sometime in type 2 diabetes. It serves as an effective alternative to insulin injections. Furthermore, insulin pump delivers the insulin according to the need of body as basal rate, where small amount of insulin
Insulin Drug and Delivery Technologies Market Report 2018: Segmentation by Produ …
Global Insulin Drug and Delivery Technologies market research report provides company profile for Julphar, Ypsomed, Becton, Dickinson and Company, Sanofi, Eli Lilly and Company, Biocon and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc.
09-06-2017 | Health & Medicine
MRRSE
Smart Insulin Pens Market: Bluetooth Connected Smart Insulin Pens Allow Effectiv …
By connectivity, the Bluetooth connected smart insulin pen segment is expected to account for a value share of US$ 0.276 Mn in 2017. The segment is expected to reach a little more than US$ 2 Mn by 2027 end, registering the highest CAGR of 23.2% over the forecast period. Bluetooth connected smart insulin pens represent the future of insulin delivery devices. Such devices have an inbuilt Bluetooth connectivity feature allowing
Biosimilar Insulin Market Biosimilar Insulin Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Prologue to Insulin Biosimilars 1.1 Outline Towards Insulin 1.2 Trail of Insulin Evolution and Development Rationale Design of Insulin Molecule 2.1 Structure of Insulin Polypeptide 2.2 Biosynthesis of Insulin 2.3 Secretion of Insulin Mechanism of Insulin in Diabetics 3.1 Glucose Metabolism of Insulin 3.2 Impact of Insulin Dysregulation in Diabetes 1 3.3 Impact